mRNA Technology

Vaccine Development Vaccine Research Cancer Research Cancer Vaccines Vaccine Technology Therapeutics Cancer Treatment Research and Development mRNA Vaccines Vaccines Cancer Therapies Lipid Nanoparticles Cancer Immunotherapy Drug Development Vaccine Production Cell Reprogramming Medical Research Immunotherapy Therapeutic Applications Clinical Trials

4 ARTICLES

2w ago

Moderna and Merck Report Positive Phase 3 Topline for Personalized Melanoma Vaccine

A topline interim readout pushed Moderna shares to multiyear highs and preceded a $2.6 billion financing ahead of detailed results at the Oct. 24 ESMO presentation.

21 ARTICLES

last mo.

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

46 ARTICLES

2mo ago

FDA Approves Moderna’s mFlusiva for Adults 50 and Older

7 ARTICLES

8mo ago

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

40 ARTICLES

8mo ago

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

5 ARTICLES

9mo ago

Liver-Targeted mRNA Therapy Rejuvenates T-Cell Immunity in Aging Mice

5 ARTICLES

11mo ago

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

9 ARTICLES

last yr.

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

8 ARTICLES

last yr.

US Cuts $500 Million in mRNA Vaccine Research Funding

5 ARTICLES

last yr.

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial